5/21/2020
A Gluten-Digesting Enzyme Passes Phase 1 Trial
TAK-062, an orally administered synthetic enzyme that survives the acidity of the stomach and digests gluten effectively, has passed its phase 1 clinical drug trial, indicating it is safe to use in celiac patients.
Continue Reading